Reddys Obeda was launched at about 4,200 per month , Glenmarks vial format was estimated around 1,300 to 1,760 per month , and Alkem announced pricing starting at roughly 1,800 per month
Kopp K, Glotfelty E, Li Y, et al (2023) Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
But individual response varies
How We Compare to Other Options Real Results from Real Johnson City Patients What Our Clients Are Saying Brandi H
9 The current advantages, research stage and areas of opportunity of small molecule GLP-1RAs is summarized in Figure 3
GPs are likely to play a key role in identifying people who will benefit from these medicines through preventive health actions, and through patient education and support